Literature DB >> 21117001

Estimation of cutoff for the Severity of Dependence Scale (SDS) for opiate dependence by ROC analysis.

I Iraurgi Castillo1, F González Saiz, O Lozano Rojas, M A Landabaso Vázquez, J M Jiménez Lerma.   

Abstract

BACKGROUND: The Severity of Dependence Scale (SDS) is a five-item scale that has been reported to be a reliable and valid screening instrument for dependence in several types of substances. Optimal cutoff points on the SDS indicative of clinically significant dependence have been determined for a large range of substance types, however, to date no data have been reported on its performance in a population with opiate dependence. SAMPLE: A structured interview was administered to 315 opiate-dependent patients in treatment.
METHOD: The diagnostic performance of the SDS was measured via Receiver Operating Characteristic (ROC) analysis according to the DSM-IV diagnosis of heroin dependence, as measured by section 12 of the Schedule for Clinical Assessment in Neuropsychiatry (SCAN).
RESULTS: ROC analysis revealed the SDS to be a test of high diagnostic utility for the measurement of opiate dependence (Area Under Curve =0.8875). The cut-off point on the SDS at which there is optimal discrimination between the presence and absence of a diagnosis of heroin dependence was found to be 5 (i.e. a score of 5 or more). This score provides the best trade-off between sensitivity (83.15%) and specificity (84.51%). Similar results were found for heroin current consumption (AUC = 0.8325; cut-off = 5; sensitivity = 77.94 and specificity = 77.33).
CONCLUSION: The SDS can be recommended as an effective short instrument for the discrimination of the degree of dependency and heroin consumption in the clinical area.

Entities:  

Mesh:

Year:  2010        PMID: 21117001

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  8 in total

1.  Anxiety, depression, and opioid misuse among adults with chronic pain: the role of emotion dysregulation.

Authors:  Andrew H Rogers; Michael F Orr; Justin M Shepherd; Jafar Bakhshaie; Joseph W Ditre; Julia D Buckner; Michael J Zvolensky
Journal:  J Behav Med       Date:  2020-06-27

2.  Anxiety sensitivity and opioid misuse and dependence among trauma-exposed adults with chronic pain.

Authors:  Michael J Zvolensky; Andrew H Rogers; Justin M Shepherd; Anka A Vujanovic; Jafar Bakhshaie
Journal:  J Behav Med       Date:  2020-02-18

3.  Anxiety sensitivity and opioid misuse among opioid-using adults with chronic pain.

Authors:  Andrew H Rogers; Brooke Y Kauffman; Jafar Bakhshaie; R Kathryn McHugh; Joseph W Ditre; Michael J Zvolensky
Journal:  Am J Drug Alcohol Abuse       Date:  2019-03-21       Impact factor: 3.829

4.  The Interaction of Alcohol Use and Cannabis Use Problems in Relation to Opioid Misuse Among Adults with Chronic Pain.

Authors:  Andrew H Rogers; Justin M Shepherd; Daniel J Paulus; Michael F Orr; Joseph W Ditre; Jafar Bakhshaie; Michael J Zvolensky
Journal:  Int J Behav Med       Date:  2019-10

5.  The Severity of Dependence Scale detects medication misuse and dependence among hospitalized older patients.

Authors:  Socheat Cheng; Tahreem Ghazal Siddiqui; Michael Gossop; Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  BMC Geriatr       Date:  2019-06-24       Impact factor: 3.921

6.  Disentangling psychopathology, substance use and dependence: a factor analysis.

Authors:  Jaime Delgadillo; Jan R Böhnke; Elizabeth Hughes; Simon Gilbody
Journal:  BMC Psychiatry       Date:  2016-08-08       Impact factor: 3.630

7.  Longitudinal Substance Use and Biopsychosocial Outcomes Following Therapeutic Community Treatment for Substance Dependence.

Authors:  Petra K Staiger; Paul Liknaitzky; Amelia J Lake; Stefan Gruenert
Journal:  J Clin Med       Date:  2020-01-01       Impact factor: 4.241

8.  Examination of multilevel domains of minority stress: Implications for drug use and mental and physical health among Latina women who have sex with women and men.

Authors:  Alice Cepeda; Kathryn M Nowotny; Jessica Frankeberger; Esmeralda Ramirez; Victoria E Rodriguez; Tasha Perdue; Avelardo Valdez
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.